
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES49
A study which compared metformin monotherapy with metformin and nateglinide63 found no
differences across the lipid profile between these two groups except for triglycerides which were
reduced significantly in the metformin and nateglinide group (nateglinide 120 mg tablets thrice
daily). Level 1+

[@Marre_2002]

